Oral Semaglutide at a Dose of 25mg in Adults with Overweight or Obesity
Though these medications are not intended as aesthetic treatments , their noticeable effects on body composition have made them a topic of discussion in the medical aesthetics community
Endocrine Connections, 14(5), e240529
Patients with non-alcoholic fatty liver disease may actually benefit from GLP-1 receptor agonists, as clinical studies show these medications can reduce liver fat content and improve liver enzyme levels
This year, both Eli Lilly and Novo Nordisk have filed several NAD challenges against compounding pharmacies, telehealth companies and medspas marketing compounded versions of semaglutide and tirzepatide
Understanding the Cons and Potential Side Effects No medical treatment is perfect, and it is important to be realistic about the challenges